GENE ONLINE|News &
Opinion
Blog

2021-04-17| SpecialTechnology

How Liquid Biopsies are Helping in Detection of Cancer Relapse?

by Ruchi Jhonsa
Share To
Circulating tumor cells (CTCs) are a rare subset of cells found in the blood of cancer patients, functioning as a seed for metastasis. Identifying them early on with liquid biopsies can help determine the occurrence of relapse. At the AACR virtual conference, Dr. Alberto Bardelli, Dr. Caroline Dive, and Dr. Sarah-Jane Dawson discussed how CTCs can be used to identify tumor evolution and minimal residual disease.

GO Prime with only $1.49 now

SUBSCRIBE NOW
LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
READ MORE
EVENT
2023-10-04
BioFuture 2023
New York city,USA
2023-11-16
3rd INTERNATIONAL CONFERENCE ON NUTRITION AND HEALTHCARE
Dubai, UAE
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top